Protara Therapeutics Inc (TARA) — Capital Reinvestment Ratio

Latest as of September 2023: 0.29x

Protara Therapeutics Inc (TARA) has a Capital Reinvestment Ratio of 0.29x as of September 2023, meaning it reinvests 0% of its operating cash flow ($128.00K) in capital expenditures ($37.00K). See debt-free asset ratio of Protara Therapeutics Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.29x

Capex / Operating Cash Flow

Operating Cash Flow

$128.00K

USD

Capital Expenditures

$37.00K

USD

Data as of

Sep 2023

Most recent filing

Annual Capital Reinvestment Ratio for Protara Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Protara Therapeutics Inc from None to None. For live market cap and broader valuation context, see TARA market cap.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow